Related references
Note: Only part of the references are listed.Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
George Hripcsak et al.
JAMA INTERNAL MEDICINE (2020)
Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network
Ruijun Chen et al.
JCO CLINICAL CANCER INFORMATICS (2020)
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Marc A. Suchard et al.
LANCET (2019)
2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
Hae-Young Lee et al.
CLINICAL HYPERTENSION (2019)
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
David M. Reboussin et al.
HYPERTENSION (2018)
Evaluating large-scale propensity score performance through real-world and synthetic data experiments
Yuxi Tian et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Angiotensin-Converting Enzyme Inhibitors in Hypertension To Use or Not to Use?
Franz H. Messerli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data
Martijn J. Schuemie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Ten Commandments of the 2018 ESC/ESH HTN Guidelines on Hypertension in Adults
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Association of Hemoglobin A(1C) Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin Analysis From the Observational Health Data Sciences and Informatics Initiative
Rohit Vashisht et al.
JAMA NETWORK OPEN (2018)
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network
Jon D. Duke et al.
EPILEPSIA (2017)
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
Louis Potier et al.
HEART (2017)
Accuracy of an automated knowledge base for identifying drug adverse reactions
E. A. Voss et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2017)
ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis
Fabrizio Ricci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Characterizing treatment pathways at scale using the OHDSI network
George Hripcsak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Robust empirical calibration of p-values using observational data
Martijn J. Schuemie et al.
STATISTICS IN MEDICINE (2016)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Massive Parallelization of Serial Inference Algorithms for a Complex Generalized Linear Model
Marc A. Suchard et al.
ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION (2013)
Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System
Patrick B. Ryan et al.
DRUG SAFETY (2013)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninangiotensinaldosterone system inhibitors involving 158 998 patients
Laura C. van Vark et al.
EUROPEAN HEART JOURNAL (2012)
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
CORD: COmparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockers
J. Spinar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
David B. Matchar et al.
ANNALS OF INTERNAL MEDICINE (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antihypertensive medication and the risk of acute pancreatitis:: The European case-control study on drug-induced acute pancreatitis (EDIP)
Ingo A. Eland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Angiotensin receptor blockers may increase risk of myocardial infarction: Unraveling the ARB-MI paradox
Martin H. Strauss et al.
CIRCULATION (2006)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
AH Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Health outcomes associated with various antihypertensive therapies used as first-line agents - A network meta-analysis
BN Psaty et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
H Lithell et al.
JOURNAL OF HYPERTENSION (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Share Paper
